C1s inhibitors (Ra Pharmaceuticals)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameC1s inhibitors (Ra Pharmaceuticals)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionComplement C1s inhibitors
TargetsComplement C1s
Therapy Area/IndicationsAutoimmune DiseasesCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRa Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRa Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A